Ala Khamees is a specialist in ophthalmology, working as a "Facharzt" (medical specialist) at the University Hospital Düsseldorf, Germany. He has held roles in various ophthalmology clinics, including as an ophthalmologist at the OP Zentrum in Düsseldorf and as the medical director of the MVZ Dardenne Remscheid. His expertise includes areas like vitreoretinal surgery and other medical and surgical treatments related to eye conditions. He completed his medical education at the University of Jordan, where he graduated in 2005

Sarah Ballout is a research associate at the Peter L. Reichertz Institute for Medical Informatics, which is part of both TU Braunschweig and Hannover Medical School (MHH), Germany. She contributes to projects within the HiGHmed initiative, which focuses on improving healthcare through digital transformation, including the creation of medical data integration centers. Her work intersects with digital healthcare innovations, particularly in the field of medical informatics​

Dr. Nuttamon Srisamran is a distinguished glaucoma specialist based in Thailand. She currently heads the Advanced Ophthalmology Center at The World Medical Center in Nonthaburi and serves as a clinical instructor at the Department of Ophthalmology, Thammasat University. Her career includes a comprehensive academic and clinical background, with a medical degree from Chulalongkorn University, followed by specialized training in glaucoma at the Hamilton Glaucoma Center at the University of California, San Diego, and further fellowship training in pediatric glaucoma at the Queen Sirikit National Institute of Child Health.

Yasmine Derradji is a doctoral student and research assistant at the University of Lausanne in Switzerland, working within the Department of Ophthalmology at the Jules-Gonin Eye Hospital. Her research focuses on age-related macular degeneration (AMD), specifically investigating molecular biomarkers in patients with neovascular AMD who show incomplete responses to anti-VEGF treatments. Derradji is involved in proteomic and multiplex analyses to explore inflammatory and angiogenic pathways that may contribute to the residual exudative activity in AMD despite treatment